O'Cearbhaill RE, Miller A, Soslow RA, Lankes HA, et al. A phase 2 study of dasatinib in recurrent clear cell carcinoma of the ovary, fallopian tube, peritoneum or endometrium: NRG oncology/gynecologic oncology group study 0283. Gynecol Oncol 2023;176:16-24.
PMID: 37418832